Top Page
kneat.com
(TSX:KSI)
kneat.com (KSI) vs. iShares MSCI Canada ETF (EWC)
kneat.com Business Overview & Revenue Model
kneat.com Earnings Call Summary
kneat.com Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 48.94M | 34.22M | 23.75M | 15.50M | 7.42M |
| Gross Profit | 36.76M | 23.13M | 14.65M | 9.32M | 2.88M |
| EBITDA | 6.27M | -5.77M | -3.20M | -5.11M | -2.30M |
| Net Income | -7.73M | -14.12M | -9.15M | -9.86M | -5.88M |
Balance Sheet | |||||
| Total Assets | 124.58M | 64.50M | 50.41M | 51.28M | 33.80M |
| Cash, Cash Equivalents and Short-Term Investments | 58.89M | 15.25M | 12.28M | 21.56M | 8.66M |
| Total Debt | 29.26M | 28.17M | 7.09M | 7.86M | 9.52M |
| Total Liabilities | 59.51M | 49.73M | 24.43M | 17.09M | 14.59M |
| Stockholders Equity | 65.07M | 14.76M | 25.98M | 34.19M | 19.21M |
Cash Flow | |||||
| Free Cash Flow | -10.09M | -18.39M | -9.82M | -7.74M | -9.28M |
| Operating Cash Flow | 9.79M | -1.28M | 2.99M | 2.31M | -1.98M |
| Investing Cash Flow | -17.52M | -15.97M | -11.91M | -10.04M | -6.43M |
| Financing Cash Flow | 50.62M | 20.27M | -383.91K | 21.20M | 13.11M |
kneat.com Technical Analysis
kneat.com Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | C$724.13M | 246.92 | 2.15% | ― | 35.97% | -59.04% | |
67 Neutral | C$530.75M | ― | -4.56% | ― | 42.93% | 85.95% | |
55 Neutral | C$7.80M | ― | -244.35% | ― | -71.31% | -53.11% | |
52 Neutral | $7.65B | 0.16 | -63.14% | 2.08% | 16.38% | 0.82% | |
49 Neutral | C$20.88M | ― | 366.78% | ― | -39.00% | -11.21% | |
| ― | $27.55M | ― | -507.20% | ― | ― | ― | |
| ― | $13.09M | ― | -9999.00% | ― | ― | ― |
kneat.com Corporate Events
Kneat.com has announced a change in its senior leadership with the retirement of CFO Hugh Kavanagh, who has significantly contributed to the company’s growth. Dave O’Reilly, with a strong background in scaling businesses and financial strategy, will take over as CFO, potentially impacting Kneat’s operations and market positioning positively as the company continues to scale in the Life Sciences sector.
The most recent analyst rating on (TSE:KSI) stock is a Buy with a C$4.90 price target. To see the full list of analyst forecasts on kneat.com stock, see the TSE:KSI Stock Forecast page.
Kneat.com has announced a multi-year Master Services Agreement with a major healthcare technology and diagnostics company to digitize its validation processes using the Kneat Gx platform. This partnership highlights the growing trend of digital validation in the life sciences industry, as evidenced by the increasing percentage of organizations adopting such technologies. The agreement is expected to enhance efficiency, quality, and compliance for the healthcare company, reinforcing Kneat’s position as a leader in digital validation solutions.
The most recent analyst rating on (TSE:KSI) stock is a Buy with a C$4.90 price target. To see the full list of analyst forecasts on kneat.com stock, see the TSE:KSI Stock Forecast page.
Kneat.com announced the results of its 2025 Annual General Meeting, where all director nominees were elected to the board, and KPMG LLP was re-appointed as auditors. This reaffirms the company’s stable governance and commitment to maintaining high standards in its operations, potentially enhancing stakeholder confidence and industry positioning.
The most recent analyst rating on (TSE:KSI) stock is a Buy with a C$4.90 price target. To see the full list of analyst forecasts on kneat.com stock, see the TSE:KSI Stock Forecast page.
Kneat.com has announced a significant three-year Master Services Agreement with a major U.S.-based manufacturer of clinical diagnostics, which operates globally. This agreement will see the diagnostics company initially use Kneat’s digital platform, Kneat Gx, to digitize its equipment validation process, reflecting a broader industry trend towards digitalization for improved quality and compliance. This partnership underscores Kneat’s market position as a leader in digital validation solutions, promising enhanced efficiency and compliance benefits for its clients.
The most recent analyst rating on (TSE:KSI) stock is a Buy with a C$4.90 price target. To see the full list of analyst forecasts on kneat.com stock, see the TSE:KSI Stock Forecast page.
Kneat.com announced record revenue for the first quarter of 2025, with total revenue reaching $14.7 million, marking a 37% increase year over year. The company also reported a significant rise in Annual Recurring Revenue and gross profit, indicating strong growth and progress toward profitability. Recent strategic partnerships and client acquisitions in the life sciences sector, along with the expansion of its executive team, underscore Kneat’s commitment to scaling its operations and enhancing its market position.
Kneat.com has announced an expansion of its executive leadership team to enhance product innovation and strategic planning. Kevin Fitzgerald, co-founder and current Chief Product Officer, will transition to the role of Chief Innovation Officer, focusing on strategic vision and product innovation. Donal O’Sullivan, with over 25 years of experience in software development leadership, will join as the new Chief Product Officer. This leadership change aims to strengthen Kneat’s position in the market by optimizing product excellence and capturing growth opportunities.
Kneat.com announced it will release its first-quarter financial results for 2025 on May 7, after the TSX market closes. The company will host a webcast conference call on May 8, led by CEO Eddie Ryan and CFO Hugh Kavanagh, to discuss the results with analysts. This announcement is significant as it provides stakeholders with insights into the company’s financial health and operational performance, potentially influencing market perceptions and investment decisions.